FairJourney Biologics is a privately established company with an outstanding track record of biotech and biopharmaceutical partners (Merus, argenX, BMS, Bayer, among others), offering a range of assets and services on antibody discovery, engineering, production, characterization up to cell line development stages. Our naïve and immune libraries from humans, rodents and llama, together with our know-how and internal technological development allow us to contribute to the pipeline of our partners on complex targets, leading to 14 known antibodies in the clinic.

More recently, FairJourney Biologics has been joined by specialists in the field such as Tariq Ghayur (formerly Abbvie) and Rene Hoet (formerly Bayer), creating a panel of available scientists as service to support complex antibody projects.

From target validation up to cell line development and pre-CMC reporting, FairJourney Biologics is a one stop shop leader in antibody services. As of 2022, the company has a headcount of above 200 staff members and a track record of more than 800 projects on a variety of areas.

Biotechnology

FairJourney Biologics

António Parada

Ana Meneses

Rene Hoet

Joseph K.

Graça Maia

Peter S.

Daniela Teixeira

The Scientific and Research team at FairJourney Biologics conducts cutting-edge research and development in antibody discovery and engineering. This team leverages extensive expertise and advanced methodologies to validate targets, characterize antibodies, and develop cell lines, contributing crucial scientific insights and innovations that support complex antibody projects for biotech and biopharmaceutical partners.

Scientific and Research

Leadership Team

Business Development and Alliance

Scientific and Research

About

Team members

Other teams at FairJourney Biologics

Leadership Team

Business Development and Alliance